Aspire Biopharma Holdings, Inc. - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
ASBP Nasdaq 2840 aspirebiolabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aspire Biopharma Holdings, Inc.

Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma's BUZZ BOMB(TM) - Jul 20th, 2026 6:30 am
OTC Markets Life Sciences Investor Forum: Stephen Quesenberry, General Counsel and Director of Product Development, of Aspire Biopharma with Zacks SCR’s David Bautz, PhD - Jul 10th, 2026 4:33 am
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - Jun 26th, 2026 6:35 am
Aspire Biopharma's BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs - Jun 24th, 2026 6:30 am
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th - Jun 23rd, 2026 6:35 am
Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th - Jun 17th, 2026 8:57 am
Aspire Biopharma Acquires Automotive Supplier Dura Driver Control Systems in $30M Deal (ASBP) - Jun 12th, 2026 8:20 am
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier? - Jun 12th, 2026 8:14 am
Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue - Jun 12th, 2026 6:30 am
Aspire Biopharma Issues Shareholder Letter - May 28th, 2026 6:30 am
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members - May 27th, 2026 6:30 am
Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program - May 13th, 2026 11:46 am
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio - May 7th, 2026 9:00 am
ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Apr 30th, 2026 3:27 am
Aspire Biopharma Announces $5.0 Million Share Repurchase Program - Apr 27th, 2026 6:30 am
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Apr 20th, 2026 6:30 am
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo - Apr 17th, 2026 6:00 am
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue - Apr 16th, 2026 6:30 am
Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion - Apr 15th, 2026 6:00 am